Yesterday, Germany, France, Italy, Spain, Luxembourg, Portugal, and Slovenia joined a growing list of European nations that put a hold on jabbing their citizens with the AstraZeneca COVID-19 vaccine.
Germany’s health ministry tweeted, “Following reports of cerebral vein thrombosis in connection with the vaccination in Germany and Europe, the Paul Ehrlich Institute considers further investigations to be necessary.”
On Sunday, Ireland and the Netherlands warned against anyone getting this vaccine due to concerns about blood clotting.
This followed Saturday’s report from the Norwegian Medicines Agency citing four new cases of serious blood clotting soon after the administration of the AZ vaccine.
On Friday, Bulgaria and Thailand have joined in calling for a halt. March Market Watch reported that Bulgarian Prime Minister Boyko Borissov said, “The suspension will last until the European Medicines Agency issues a written statement that it is safe.” This comes after a 57-year-old Bulgarian woman died after receiving her first dose.
In Thailand, the country’s Prime Minister, Prayuth Chan-o-cha, canceled the event in which he was to be the first Thai to receive the AstraZeneca jab. A member of Thailand’s vaccination committee stated, “When there is an adverse event, we don’t need to be in rush.”
The country, however, is continuing to allow injections with the Chinese-made vaccine called Sinovac.
Also, on Friday, the EU medical regulator voiced concern over 41 cases of anaphylaxis, which was reported by people who received the AstraZeneca shot. This is a serious allergic reaction that causes throat or tongue swelling, shortness of breath, vomiting, lightheadedness, and low blood pressure.
After an Italian serviceman died of a heart attack a day after getting the vaccine, the Italian government called for a halt on further use of the specific batch suspected of causing the problem. (The country is allowing other batches to be dispensed.) Austria and Romania have also banned the specific batch in question.
Last Thursday, Euronews reported that Denmark, Iceland, and Norway have halted all AstraZeneca COVID-19 vaccinations due to blood clot issues.
Denmark’s Health Authority issued a statement that the full suspension comes as a “precautionary” move until it can be proven there is no cause-and-effect connection.
The European Medicines Agency stated that as of 9 March, 22 cases of blood clots have been reported.
EuroNews also noted that a number of countries have stopped all vaccinations from a certain batch of the AstraZeneca vaccine due to the death of a 49-year-old Austrian nurse from “severe blood coagulation problems” just one day after receiving the vaccine.
Latvia, Estonia, Lithuania, and Luxemburg followed suit and banned any vaccinations from this particular batch.
In the U.K., which has one of the most aggressive vaccination campaigns in the world and where the AstraZeneca vaccine has been widely used, the country’s medicines regulator stated there was no proof the blood clots were caused by the shots and that “people should still go and get their COVID-19 vaccine when asked to do so.”
Not So Fast!
A very different reaction came from Hendrik Streeck, a professor of virology at the University of Bonn, who confirmed the Danish decision to halt all AstraZeneca vaccines was a proper precaution.
On 23 January, AstraZeneca informed the EU that deliveries of the vaccine would need to be reduced by 60 percent due to “production problems.”
TRENDPOST: On 4 December, the Healthline website published the article, “What to Know About the AstraZeneca Vaccine Controversy.” This included:
“AstraZeneca announced that its vaccine is 70 percent effective, but a major dosing error during the trials may have affected the overall efficacy.
Some clinical trial participants were mistakenly given half a dose rather than a full dose in their first round of shots.
Researchers discovered that those who were given the weaker dosage produced a better immune response.”
We note this AstraZeneca article to emphasize the fact that these “Operation Warp Speed” vaccinations have been rushed into the marketplace with no scientific efficacy as to what long- and short-term adverse health effects may occur.
In addition, according to Wall Street and politicians, much of the economic recovery is based on mass COVID vaccination of the population.
While the U.K., Israel, and the U.S. are in the race for mass vaccinations, the vaccine rates per population in Europe remain low, and they will continue to lag as reports of negative aftereffects increase. Thus, the slower the vaccine rate, the longer lockdowns will persist and the further economies will fall.
